Home › Free Stock Grades › KRRO
Korro Bio, Inc. (KRRO) Stock Grade
KRRO · Healthcare
C
Market Cap
$94.7M
P/E Ratio
—
Revenue Growth (YoY)
+181.5%
Net Margin
-1834.5%
Return on Equity
—
Dividend Yield
None
About Korro Bio, Inc.'s fundamentals
Korro Bio is a small-cap biotechnology company with a market capitalization of $94.7 million that is in early-stage development, as evidenced by its net loss in the latest annual statement and unavailable profitability metrics. The company is experiencing significant momentum in revenue growth, which surged 181.5% year-over-year, indicating expanding business activity. However, its net margin of -1834.5% reflects substantial operating losses relative to its revenue base, which is common for development-stage biotech firms investing heavily in research and clinical programs. The company does not pay a dividend.